Key players in Lipid Nanoparticles
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Genevant Sciences | — | 33 reports |
| 2 | Precision NanoSystems (Cytiva) | — | 33 reports |
| 3 |  Evonik Industries AG |
evonik.com (opens in a new tab) | 132 reports |
| 4 |  Merck KGaA |
merckgroup.com (opens in a new tab) | 297 reports |
| 5 | Croda International PLC | — | 99 reports |
Also active in Lipid Nanoparticles
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Genprex, Inc. |
|
| Prime Medicine, Inc. |
|
| CorrectSequence Therapeutics Co., Ltd |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Lipid Nanoparticles
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Genprex, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Prime Medicine, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- CorrectSequence Therapeutics Co., Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Lipid Nanoparticles reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Lipid Nanoparticles report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.